blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1914232

EP1914232 - N-DIHYDROXYALKYL-SUBSTITUTED 2-OXOIMIDAZOLE DERIVATIVES [Right-click to bookmark this link]
Former [2008/17]N-DIHYDROXYALKYL-SUBSTITUTED 2-OXOIMIDAZOLE DERIVATIVE
[2010/25]
StatusNo opposition filed within time limit
Status updated on  21.10.2011
Database last updated on 26.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU
published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
MSD K.K.
Kitanomaru Square 1-13-12 Kudankita Chiyoda-ku Tokyo
102-8667 / JP
[2011/11]
Former [2008/17]For all designated states
BANYU PHARMACEUTICAL CO., LTD.
Kitanomaru Square 1-13-12, Kudan-kita Chiyoda-ku
Tokyo 102-8667 / JP
Inventor(s)01 / HASHIMOTO, Masaya BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi Ibaraki 300-2611 / JP
02 / IWASAWA, Yoshikazu BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
03 / KAWAMOTO, Hiroshi BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
04 / OHTA, Hisashi BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
05 / OZAKI, Satoshi BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
06 / SAGARA, Takeshi BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
07 / SAKOH, Hiroki BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
08 / SATOH, Atsushi BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
 [2010/28]
Former [2008/17]01 / HASHIMOTO, Masaya, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi Ibaraki 300-2611 / JP
02 / IWASAWA, Yoshikazu, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
03 / KAWAMOTO, Hiroshi, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
04 / OHTA, Hisashi, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
05 / OZAKI, Satoshi, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
06 / SAGARA, Takeshi, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
07 / SAKOH, Hiroki, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
08 / SATOH, Atsushi, BANYU PHARMACEUTICAL CO., LTD.
Tsukuba Research Institute, 3, Okubo
Tsukuba-shi, Ibaraki 300-2611 / JP
Representative(s)Hussain, Deeba, et al
Merck Sharp & Dohme Corp.
120 Moorgate
London, EC2M 6UR / GB
[N/P]
Former [2008/17]Hussain, Deeba, et al
Merck & Co., Inc. Hertford Road Hoddesdon
Hertfordshire EN11 9BU / GB
Application number, filing date06781147.111.07.2006
[2008/17]
WO2006JP314122
Priority number, dateJP2005020426413.07.2005         Original published format: JP 2005204264
[2008/17]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007007890
Date:18.01.2007
Language:JA
[2007/03]
Type: A1 Application with search report 
No.:EP1914232
Date:23.04.2008
Language:EN
[2008/17]
Type: B1 Patent specification 
No.:EP1914232
Date:15.12.2010
Language:EN
[2010/50]
Search report(s)International search report - published on:JP18.01.2007
(Supplementary) European search report - dispatched on:EP24.09.2009
ClassificationIPC:C07D401/04, A61K31/454, A61P3/04, A61P9/00, A61P9/02, A61P9/10, A61P13/02, A61P19/02, A61P19/06, A61P25/06, A61P25/14, A61P25/16, A61P25/18, A61P25/24, A61P25/28, A61P29/00, A61P43/00
[2008/17]
CPC:
C07D401/04 (EP,KR); A61K31/454 (KR); A61P13/02 (EP);
A61P19/00 (EP); A61P19/02 (EP); A61P19/06 (EP);
A61P25/00 (EP); A61P25/02 (EP); A61P25/04 (EP);
A61P25/06 (EP); A61P25/14 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/24 (EP); A61P25/28 (EP);
A61P25/36 (EP); A61P29/00 (EP); A61P3/04 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/02 (EP);
A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/17]
Extension statesALNot yet paid
BANot yet paid
HR13.02.2008
MKNot yet paid
RSNot yet paid
TitleGerman:N-DIHYDROXYALKYL-SUBSTITUTIERTE 2-OXOIMIDAZOLDERIVATE[2008/17]
English:N-DIHYDROXYALKYL-SUBSTITUTED 2-OXOIMIDAZOLE DERIVATIVES[2010/25]
French:DERIVES DU 2-OXOIMIDAZOLE A SUBSTITUTION N-DIHYDROXYALKYLE[2010/25]
Former [2008/17]N-DIHYDROXYALKYL-SUBSTITUTED 2-OXOIMIDAZOLE DERIVATIVE
Former [2008/17]DÉRIVÉ DU 2-OXOIMIDAZOLE À SUBSTITUTION N-DIHYDROXYALKYLE
Entry into regional phase11.01.2008Translation filed 
13.02.2008National basic fee paid 
13.02.2008Search fee paid 
13.02.2008Designation fee(s) paid 
13.02.2008Examination fee paid 
Examination procedure13.02.2008Examination requested  [2008/17]
10.11.2009Despatch of a communication from the examining division (Time limit: M04)
18.03.2010Reply to a communication from the examining division
23.06.2010Communication of intention to grant the patent
26.10.2010Fee for grant paid
26.10.2010Fee for publishing/printing paid
Opposition(s)16.09.2011No opposition filed within time limit [2011/47]
Fees paidRenewal fee
31.07.2008Renewal fee patent year 03
31.07.2009Renewal fee patent year 04
02.08.2010Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
DK15.12.2010
EE15.12.2010
FI15.12.2010
HU15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
TR15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
IE11.07.2011
LU11.07.2011
MC31.07.2011
[2013/45]
Former [2013/44]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
DK15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
TR15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
IE11.07.2011
LU11.07.2011
MC31.07.2011
Former [2013/25]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
DK15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
IE11.07.2011
LU11.07.2011
MC31.07.2011
Former [2012/35]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
DK15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
IE11.07.2011
MC31.07.2011
Former [2012/11]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
DK15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
MC31.07.2011
Former [2011/47]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
DK15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
Former [2011/37]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
RO15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
Former [2011/36]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
PL15.12.2010
SE15.12.2010
SI15.12.2010
SK15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
Former [2011/35]AT15.12.2010
BE15.12.2010
CY15.12.2010
CZ15.12.2010
EE15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
SE15.12.2010
SI15.12.2010
BG15.03.2011
GR16.03.2011
IS15.04.2011
PT15.04.2011
Former [2011/33]AT15.12.2010
BE15.12.2010
CY15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
SE15.12.2010
SI15.12.2010
BG15.03.2011
Former [2011/30]AT15.12.2010
CY15.12.2010
FI15.12.2010
LT15.12.2010
LV15.12.2010
SE15.12.2010
SI15.12.2010
BG15.03.2011
Former [2011/19]LT15.12.2010
Documents cited:Search[DXY]EP0990653  (BANYU PHARMA CO LTD [JP]) [DXY] 1-15 * paragraphs [0001] , [0022]; examples 9,10,20,69,70,128; claims 1,17 *;
 [Y]WO0139775  (EURO CELTIQUE SA [LU], et al) [Y] 1-15* claims 1,19 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.